Opioid addiction can affect health, work, family, and daily life. Many patients who start with prescription pain relievers may develop substance use disorders that are hard to stop without support. Medication assisted treatment MAT helps address brain chemistry, brain circuits, psychological cravings, and the physical aspects of opioid addiction. Research shows MAT programs can be a highly effective tool for people struggling with opioid use disorder. These programs use medication and therapy in combination to help the whole patient, reduce negative effects, and support the recovery journey.
What Medication Assisted Treatment Means for Opioid Addiction
Medication assisted treatment uses FDA-approved medication with counseling and recovery support to treat opioid addiction. The medications can help reduce cravings, ease withdrawal symptoms, and lower the risk of relapse or overdose. Buprenorphine, methadone, and naltrexone each work in different ways, so a provider should match the medication to the person’s opioid use history, health needs, and recovery goals. MAT does not replace one addiction with another when it is used as prescribed. It helps stabilize the brain and body so a person can focus on therapy, family support, work, and daily recovery. At New Hope Healthcare Institute, MAT can be part of a larger treatment plan that also addresses mental health, coping skills, and long-term stability.
Conditions Medication Assisted Treatment Can Treat
Medication assisted treatment treats opioid use disorder linked to fentanyl, heroin, prescription opioids, oxycodone, hydrocodone, morphine, codeine, and other opioid drugs in individuals who have a substance use disorder. MAT can also help people who experience opioid cravings, withdrawal symptoms, repeated relapse, or a high risk of overdose. MAT may also treat alcohol use disorder, and common medications used to treat alcohol include acamprosate, disulfiram, and naltrexone. It can also help individuals with co-occurring mental health conditions such as depression, anxiety, PTSD, bipolar disorder, and sleep disorders.
Why MAT Matters for Opioid Recovery in Knoxville
MAT matters because opioid addiction continues to affect individuals and families throughout Knoxville and East Tennessee. Fentanyl and other opioids remain major contributors to overdose deaths and addiction-related challenges across the region.
MAT helps reduce cravings, manage withdrawal symptoms, and lower relapse risk. It can provide stability that allows individuals to focus on counseling, recovery skills, employment, family relationships, and long-term recovery goals.
Signs and Symptoms of Opioid Addiction That May Point to MAT
- Strong opioid cravings
- Withdrawal symptoms when opioid use stops
- Using more opioids than intended
- Unsuccessful attempts to quit
- Needing larger amounts to achieve the same effect
- Spending significant time obtaining or using opioids
- Using opioids despite negative consequences
- Loss of interest in activities once enjoyed
- Doctor shopping or early prescription refills
- Using fentanyl, heroin, or non-prescribed opioid pills
- Repeated relapse after treatment or detox
- History of overdose or near overdose
Understanding Buprenorphine for Opioid Use Disorder Treatment
Buprenorphine is a partial opioid agonist medication that helps reduce opioid cravings and withdrawal symptoms. It works by partially activating opioid receptors, helping stabilize the brain while producing fewer euphoric effects than full opioids and still easing cravings and withdrawal symptoms.
Buprenorphine is available in several forms, including Suboxone, Subutex, and Sublocade. It is often used in outpatient treatment settings and can support long-term recovery when combined with counseling and behavioral therapies.
How Methadone Supports Long-Term Opioid Recovery
Methadone is a long-acting medication used to treat opioid use disorder. It helps reduce cravings and withdrawal symptoms while allowing individuals to function more normally in daily life. Methadone may be beneficial for people with severe opioid dependence or a history of repeated relapse. Treatment is typically provided through certified opioid treatment programs that offer monitoring and support.
What to Know About Naltrexone and Vivitrol
Naltrexone is a medication that blocks the effects of opioids. Vivitrol is the extended-release injectable form of naltrexone that is given once per month. Unlike buprenorphine and methadone, naltrexone does not reduce withdrawal symptoms. It is critical that individuals complete detox and be opioid-free for 7–10 days before starting treatment to avoid triggering withdrawal.
Buprenorphine vs Methadone vs Naltrexone
Buprenorphine helps reduce cravings and withdrawal symptoms while offering flexibility through office-based treatment. Methadone may be more appropriate for individuals with severe opioid dependence who need structured care.
Naltrexone is used in treating opioid use disorder by blocking opioid effects after detox is complete. The best medication depends on addiction severity, treatment history, relapse risk, medical needs, and recovery goals.
How MAT Reduces Opioid Cravings and Withdrawal Symptoms
MAT helps normalize brain function by addressing the chemical imbalances caused by prolonged opioid use. Buprenorphine and methadone reduce cravings and withdrawal symptoms, and these medications restore balance in brain function, while naltrexone helps prevent opioid use by blocking opioid effects. Reducing cravings and withdrawal symptoms can help individuals stay engaged in treatment. This stability often improves participation in therapy, recovery planning, and daily responsibilities.
Benefits of Medication Assisted Treatment
- Reduces opioid cravings
- Eases withdrawal symptoms
- Lowers relapse risk
- Reduces overdose risk
- Improves treatment retention
- Supports long-term recovery
- Promotes daily stability
- Improves quality of life
- Supports employment and education goals
- Enhances participation in counseling and therapy
- Can improve family and social relationships
Opioid Addiction Prevalence in Knoxville and East Tennessee
Opioid addiction remains a significant public health concern throughout Knoxville and East Tennessee. Fentanyl, heroin, and prescription opioid misuse continue to contribute to overdose deaths, emergency department visits, and addiction treatment needs across the region. Community awareness, overdose prevention efforts, and access to evidence-based treatment remain important. MAT continues to play a key role in helping individuals recover from opioid use disorder and reduce overdose risk.
Effects and Risks of Untreated Opioid Addiction
Short-Term:
- Strong cravings
- Withdrawal symptoms
- Drowsiness and sedation
- Nausea and vomiting
- Poor judgment and decision-making
- Relationship conflicts
- Work or school problems
- Risky behaviors
- Overdose
Long-Term:
- Physical dependence
- Chronic relapse
- Increased overdose risk
- Depression and anxiety
- PTSD and other mental health concerns
- Financial difficulties
- Job loss
- Legal problems
- Family disruption
- Infectious diseases related to injection drug use
- Reduced quality of life
- Death from overdose
Research from the Mental Health Services Administration and the National Institute links drug abuse and substance abuse with higher health risks, legal problems, and criminal activity.
Who May Benefit Most From Medication Assisted Treatment
Medication assisted treatment may benefit people with opioid use disorder who struggle with cravings, withdrawal symptoms, relapse, or overdose risk. It may also help people who use fentanyl, heroin, oxycodone, hydrocodone, or other opioids and need medical support to stay stable. MAT may be a good fit for people who have tried detox but returned to opioid use. It can also support people who need outpatient care, residential treatment, counseling, and mental health support as part of one recovery plan.
The Role of Counseling and Behavioral Therapy in MAT
Counseling helps people understand the thoughts, triggers, and habits that keep opioid addiction active. Therapy can teach coping skills, relapse prevention tools, stress management, and healthier ways to respond to cravings.
Behavioral therapy also helps people address trauma, grief, family conflict, and daily stress. MAT works best when medication is paired with support that helps the person build a safer life in recovery.
MAT and Co-Occurring Mental Health Disorders
Many people with opioid addiction also live with depression, anxiety, PTSD, bipolar disorder, panic disorder, ADHD, or sleep disorders. These conditions can increase cravings, lower motivation, and make relapse more likely when they go untreated. MAT can support opioid recovery while therapy and psychiatric care address mental health symptoms. Treating both concerns together can improve stability, reduce relapse risk, and help the person stay engaged in care.
Common Misconceptions About Medication Assisted Treatment
A common misconception is that MAT replaces one addiction with another. This is not true when medications are prescribed, monitored, and used as part of a treatment plan around one drug chosen to support recovery.
Patients using MAT often face stigma and misconceptions about treatment even though it is medically supported.
Others believe people should stop opioids without medication. For many people, MAT lowers withdrawal symptoms, reduces cravings, and helps them stay in treatment long enough to recover.
Family Support and Recovery During MAT
Family support can help a person stay connected, accountable, and encouraged during MAT. Loved ones can learn about opioid addiction, medication safety, relapse warning signs, and healthy boundaries.
Family members should avoid shame-based language and focus on clear support. A calm home environment can help the person follow treatment, attend therapy, and rebuild trust over time.
How to Choose the Right MAT Option for Your Recovery Goals
The right MAT option depends on opioid use history, withdrawal risk, relapse history, medical needs, mental health symptoms, and treatment access. Buprenorphine, methadone, and naltrexone each work differently.
A provider can help compare each option and explain what to expect. The best choice should support safety, stability, therapy progress, and long-term recovery goals.
When to Seek Help
Seek help when opioid use causes cravings, withdrawal symptoms, missed responsibilities, relationship conflict, legal issues, or repeated failed attempts to quit. A history of overdose or fentanyl use also means support is needed quickly. A person should not wait until addiction becomes worse. Early treatment can reduce risk and help the person start recovery with medical and emotional support.
Medical Assisted Treatment Options
- Buprenorphine: Buprenorphine helps reduce opioid cravings and withdrawal symptoms. Common forms include Suboxone and Sublocade.
Methadone: Methadone helps manage cravings and withdrawal. It is usually provided through certified opioid treatment programs. Naltrexone: Naltrexone blocks opioid effects after detox. Vivitrol is the monthly injectable form. Counseling and Therapy: Counseling addresses triggers, stress, trauma, relapse patterns, and mental health symptoms. Outpatient Treatment: Outpatient MAT includes medication management, therapy, group support, and relapse prevention while living at home. Residential Treatment: Residential care offers structure for severe opioid addiction, relapse risk, unstable housing, or co-occurring mental health needs.
Does Insurance Cover Treatment?
Many insurance plans cover medication assisted treatment, counseling, outpatient care, and residential treatment when medically necessary. Coverage can vary by plan, provider network, medication type, and level of care. A treatment center can verify benefits before care begins. This step helps people understand costs, coverage limits, deductibles, and available treatment options.
Conclusion
Medication assisted treatment helps medications relieve withdrawal symptoms, reduce psychological cravings, and restore balance in brain circuits affected by opioid use. It can also lower the risk of opioid related overdose deaths and help many patients sustain recovery. Like care for other medical conditions such as diabetes, MAT works best with steady support and patient-centered planning. The right combination of medication, counseling, and recovery support can help people move forward with more stability and hope.
Seeking Treatment? We Can Help!
At New Hope Healthcare, as an in-network provider we work with most insurance plans, such as:
If you or a loved one are struggling with mental health challenges or substance abuse, seeking treatment and emotional support is crucial. Consulting a doctor can provide the necessary support and guidance for your teen. Reach out to New Hope Healthcare today. Our team of compassionate professionals is here to support your journey towards lasting well-being. Effective medication management is a crucial part of the treatment process to ensure safety and success. Give us a call at 866-799-0806.
Visit SAMHSA for more information.
Frequently Asked Questions
What is medication assisted treatment?
Medication assisted treatment uses medication, therapy, and support to treat opioid use disorder.
What medications are used in MAT?
MAT often uses buprenorphine, methadone, or naltrexone.
Does MAT replace one addiction with another?
No. When used as prescribed, MAT helps reduce cravings, withdrawal, and relapse risk.
Is Suboxone the same as MAT?
Suboxone is one medication used in MAT.
How long does MAT last?
MAT length varies based on symptoms, stability, and provider guidance
Can you work while on MAT?
Yes. Many people work, attend school, and care for family while in MAT.
Sources[
](https://www.ocduk.org/)
](https://nida.nih.gov/research-topics/medications-opioid-use-disorder)
- [SAMHSA Treatment Options
](https://www.samhsa.gov/substance-use/treatment/options)
- [CDC Opioid Overdose Prevention
](https://www.cdc.gov/overdose-prevention)
- [NIDA Treatment and Recovery
](https://nida.nih.gov/publications/drugs-brains-behavior-science-addiction/treatment-recovery)
- [FDA Information on Opioid Use Disorder Medications
](https://www.fda.gov/drugs/information-drug-class/information-about-medication-assisted-treatment-mat)